Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis
| Image |  |
|---|---|
| Description | scientific article published on 23 January 2018 |
| Author/s |
author: Gerd-Rüdiger Burmester |
| Publication date | March 31, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |